Nine people dead in Learjet crash in south Florida, officials say Reuters
Why HAO Stock advanced +0.99% Today — RQD Quant Desk Flash
Haoxi Health Technology Limited (Class A) (HAO) carries a Roarable Rating of D- (Sell) with 41/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is HAO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, Haoxi Health Technology Limited (Class A) (NASDAQ: HAO) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 41/100 at a spot price of $2.04 (+0.99% 1D, market cap $1.3M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 7/20. Across 132 tracked Communication Services issuers, HAO ranks #105 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does HAO compare to TNMG and FCDH in the Communication Services sector?
▼
Within the Communication Services sector (Advertising), HAO carries a Roarable D- (41/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of —. By comparison, TNMG (TNL Mediagene) holds a C- grade (60/100 RQD, P/E N/A, ROIC —, cap $2.3M) and FCDH (Forcendra Holding Limited (Class A)) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $3.1M). Among the 5-stock peer group, HAO leads on earnings multiple (N/A) while YDKG leads on capital efficiency (-11.5% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for HAO?
▼
Per HAO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001954594), Haoxi Health Technology Limited (Class A) generated $537.6K in revenue (-54.6% YoY), $3.9M in net income, and -$3.4M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Communication Services with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 92.8% Gross Margin
Disciplined Float (+0.16% YoY Shares) & executive Form 4 sales trim 13 pts from alignment
⚔️ Adversarial Opposing Case: What Could Spark a HAO Turnaround Squeeze
While HAO currently carries a cautious 41/100 (D-) rating due to Insider Conviction & Share Dilution (7/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Communication Services with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.68) and Max Pain ($2.14) forces dealer call-delta covering toward $4,569.60.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.16% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why HAO Stock advanced +0.99% Today — RQD Quant Desk Flash
Haoxi Health Technology Limited (Class A) (HAO) advanced +0.99% to $2.04, trading at 2% of its 52-week range ($1.6 – $4352). Stretched risk/reward at current multiples (96% profit margin) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($1.6 – $4352) with RSI-14 at 34 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $2.04 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 92.8% gross margin and $0 annual free cash flow.
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
The market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Haley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
Israeli strikes kill eight people in Gaza - medics say Reuters
Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Iran, Qatari mediators hold third day of talks to end US-Iran war Reuters
Qatar surges, bucking Gulf market slide on Iran war concerns Reuters
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HAO)
- ✓Walkthrough of HAO's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
HAO Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -54.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on HAO today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for HAO. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HAO)
1. Head-to-Head Communication Services Peer Comparison (HAO vs. TNMG, FCDH, YDKG, INUV)
Industry: Advertising (23 Tracked Issuers)Across 132 tracked Communication Services securities in the Roarable RQD universe, Haoxi Health Technology Limited (Class A) (HAO) ranks #105 by composite RQD confidence (41/100, grade D-) and #131 by equity capitalization ($1.3M). Within this direct 5-issuer industry benchmark cohort, HAO leads on earnings valuation at N/A trailing P/E, while YDKG leads on capital efficiency and profitability with -11.5% ROIC and -2.5% gross margin. TNMG currently holds the highest overall quantitative score in the immediate peer group at 60/100 (C-) compared with HAO at 41/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| HAO
ACTIVE
Haoxi Health Technology Limited (Class A) | D- | 41/100 | — | 96.0% | — | +0.99% | $1.3M | Benchmark Subject |
| TNMG TNL Mediagene | C- | 60/100 | — | — | — | +0.99% | $2.3M | /tnmg-vs-hao → |
| FCDH Forcendra Holding Limited (Class A) | D- | 38/100 | — | 23.7% | -35.0% | -3.27% | $3.1M | /fcdh-vs-hao → |
| YDKG Yueda Digital Holding Class A Ordinary Share | D+ | 52/100 | — | -2.5% | -11.5% | 0.00% | $5.1M | /ydkg-vs-hao → |
| INUV Inuvo Inc. | D- | 35/100 | — | 74.5% | -35.0% | -3.53% | $7.2M | /inuv-vs-hao → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0001954594In its most recent audited fiscal period (FY2025, filed 2025-06-30), Haoxi Health Technology Limited (Class A) (HAO) reported GAAP revenue of $537.6K (-54.6% vs. FY2024 revenue of $1.2M , and -98.1% cumulative change since FY2023) , GAAP net income of $3.9M, operating cash flow of -$3.4M, and free cash flow of -$3.4M (-318.2% YoY). On the balance sheet, HAO closed FY2025 with $0 in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-06-30 | $537.6K | $3.9M | -$3.4M | -$3.4M | — | — |
| FY2024 (FY) | 2024-06-30 | $1.2M | $1.3M | -$747.6K | -$802.9K | $22.1M | — |
| FY2023 (FY) | 2023-06-30 | $28.2M | $969.8K | -$872.1K | -$872.1K | — | — |
3. HAO Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs HAO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Haoxi Health Technology Limited (Class A) (NASDAQ: HAO) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 41/100 at a spot price of $2.04 (+0.99% 1D, market cap $1.3M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 7/20. Across 132 tracked Communication Services issuers, HAO ranks #105 in composite RQD confidence.
How does HAO compare to TNMG and FCDH in the Communication Services sector?
Within the Communication Services sector (Advertising), HAO carries a Roarable D- (41/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of —. By comparison, TNMG (TNL Mediagene) holds a C- grade (60/100 RQD, P/E N/A, ROIC —, cap $2.3M) and FCDH (Forcendra Holding Limited (Class A)) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $3.1M). Among the 5-stock peer group, HAO leads on earnings multiple (N/A) while YDKG leads on capital efficiency (-11.5% ROIC).
What are the biggest fundamental strengths and SEC risk factors for HAO?
Per HAO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001954594), Haoxi Health Technology Limited (Class A) generated $537.6K in revenue (-54.6% YoY), $3.9M in net income, and -$3.4M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Communication Services with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is HAO trading relative to its 50-day, 200-day, and 52-week technical levels?
HAO last traded at $2.04 (+0.99% on volume of 26,088 shares), positioning the stock -23.88% below its 50-day simple moving average ($2.68) and -99.83% below its 200-day simple moving average ($1,183.98). Across its 52-week range of $1.60 to $4,352.00, HAO sits at the 0.0% percentile with a 14-day RSI of 34.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.78 to $2.30).
HAO Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is HAO stock moving today?
Why HAO Stock advanced +0.99% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (96% profit margin) under elevated 10-year interest-rate pressure.